'Not enough action on dementia'

My Account
Logout

Create an Evening Standard Account

Use your social network

Save time by using your existing account to sign in to Evening Standard

We'll never share your information or post anything to your account without your permission

Welcome! Sign in here

Use your social network

Save time by using your existing account to sign in to Evening Standard

We'll never share your information or post anything to your account without your permission

Forgot your password ?

Registration

* indicates fields that are mandatory

Email *

Password *

Confirm Password *

First name *

Surname *

Postcode *

Country *

Mobile phone number

Username *

Gender *

Year of birth *

When you sign up...

You will have access to all our online competitions, discounted offers and can post comments on our site.

You will also receive The Weekender newsletter sent every Thursday - it’s full of fantastic offers and ideas for the weekend. You can update your email preferences in your account page when you log in.

Other newsletters and emails

Homes & Property Newsletter - Yes I want to receive the weekly email with all the latest news on property in the capital

Occasionally we would also like to send you relevant emails detailing specific offers either from ourselves or carefully selected partners. If you would prefer not to receive these then please tick the appropriate boxes below. We will never pass on your details.

I do not want to receive additional offers and information from the Evening Standard

I do not want to receive additional offers and information sent by Evening Standard on behalf of carefully selected partners

Terms and Conditions

* I have read, understood and agree to be bound by the terms and conditions of Evening Standard

Registration

Mail Sent for Registration Confirmation.

A confirmation email has been sent. Please activate your account by clicking on the activation link sent in your mail box.

The UK lags behind other European countries when it comes to early diagnosis and giving patients effective drugs, it said.

The National Audit Office (NAO) study called on the Government to show leadership and accused the Department of Health of failing to make dementia a priority.

Around 560,000 people in England are estimated to have dementia but, as the population ages, that figure is expected to rise to 750,000 by 2020.

The report comes as High Court judges consider a challenge by drugs companies, backed by the Alzheimer's Society, regarding the health watchdog's decision on the funding of medicines for early stage dementia.

The National Institute for Health and Clinical Excellence (Nice) has said the drugs Aricept (donepezil), Exelon (rivastigmine) and Reminyl (galantamine) are not cost effective for patients in the early stages of the disease.

Another drug, Ebixa (memantine), which is licensed for use in the later stages of the disease, should not be recommended for anyone, it said.

Judgment in the case has been reserved, with a ruling expected by early August.